English
Home > Products > 2'-deoxy-2'-fluoro-N-(2-methyl-1-oxopropyl)

China 2'-deoxy-2'-fluoro-N-(2-methyl-1-oxopropyl) Factory

We not only will try our greatest to offer superb companies to just about every buyer, but also are ready to receive any suggestion offered by our shoppers for 2'-deoxy-2'-fluoro-N-(2-methyl-1-oxopropyl),CAS NO 144089-97-4,144089-97-4,5'-O-[Bis(4-methoxyphenyl)phenylmethyl],guanosine 3'-2-cyanoethyl N,N-bis, We are going to do our best to fulfill your specifications and are sincerely searching forward to building mutual valuable organization romantic relationship along with you!
2'-deoxy-2'-fluoro-N-(2-methyl-1-oxopropyl), We have now a dedicated and aggressive sales team, and many branches, catering to our main customers. We have been looking for long-term business partnerships, and ensure our suppliers that they will surely benefit in both short and long run.

Related Products

Hot Products

  • 6-acetyl-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one

    6-acetyl-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one

    Product Name:6-acetyl-2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7(8H)-one
    Molecular Formula:C15H16ClN3O2
    Molecular Weight:305.76
    CAS Registry Number:1651214-73-1
  • Itraconazole

    Itraconazole

    Product Name:Itraconazole
    Molecular Formula:C35H38Cl2N8O4
    Molecular Weight;705.63
    CAS Registry Number;84625-61-6
  • Progesterone soft capsules

    Progesterone soft capsules

    Product Name:Progesterone soft capsules
    Dosage:0.1g
    Application:Progestins
  • Ethiodized oil

    Ethiodized oil

    Product Name:Ethiodized oil
    CAS Registry Number;8008-53-5
  • Silibinin

    Silibinin

    Product Name:Silibinin
    Molecular Formula:C25H22O10
    Molecular Weight;482.44
    CAS Registry Number;22888-70-6
  • Methyl 4-methoxyacetoacetate

    Methyl 4-methoxyacetoacetate

    Product Name:Methyl 4-methoxyacetoacetate
    Molecular Formula:C6H10O4
    Molecular Weight:146.14
    CAS Registry Number:41051-15-4
  • Related Blog
  • Reviews

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • How much do you know about minocycline hydrochloride?

    Minocycline hydrochloride is commonly used as its hydrochloride, which is yellow crystalline powder, odorless, bitter in taste, and can cause deterioration when exposed to light. Soluble in water, slightly soluble in ethanol, easily soluble in alkali metal hydroxide or carbonate solution.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept